The effect of theophylline on parkinsonian symptoms
Authors:
- 1 June 1994
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 46 (6) , 515-517
Abstract
— Adenosine is known to inhibit the release of dopamine from central synaptic terminals. The present open trial was therefore conducted to determine whether the adenosine receptor‐antagonist theophylline would be of value in Parkinson's disease. Fifteen parkinsonian patients were treated for up to 12 weeks with a slow release oral theophylline preparation (150 mg day−1), yielding serum theophylline levels of 4·44 mg L−1 after one week. The patients exhibited significant improvements in mean objective disability scores and 11 reported moderate or marked subjective improvement. It is suggested that theophylline might be a useful adjunct to the routine therapy of parkinsonian patients.Keywords
This publication has 15 references indexed in Scilit:
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Adenosine A2a receptors in the nucleus accumbens mediate locomotor depressionBrain Research Bulletin, 1993
- Adenosine receptors in post‐mortem human brainBritish Journal of Pharmacology, 1992
- Potassium Channel Blockers Inhibit D2 Dopamine, but Not A1Adenosine, Receptor‐Mediated Inhibition of Striatal Dopamine ReleaseJournal of Neurochemistry, 1991
- Presynaptic Adenosine A2 and N‐Methyl‐D‐Aspartate Receptors Regulate Dopamine Synthesis in Rat Striatal SynaptosomesJournal of Neurochemistry, 1991
- Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with diseaseNeuroscience, 1991
- Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseasesBrain Research, 1990
- Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediationNeuropharmacology, 1989
- Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive micePharmacology Biochemistry and Behavior, 1988
- ParkinsonismNeurology, 1967